SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CSPC Says Phase III Diabetes Drug Trial Delivers Positive Top-Line Results

CSPC Pharmaceutical Group said a Phase III trial of pruglitazone tablets combined with dapagliflozin and metformin hydrochloride extended-release tablets for type 2 diabetes achieved positive top-line results.

SquawkNews Desk

Related stories

Marvell agrees to acquire Lumentum Marvell will acquire Lumentum in an all-stock transaction. M impact | EQUITY | Nov 02, 2026, 12:18 PM UTC Gold X2 Agrees to Acquire Mineral Rights From Bold Ventures Gold X2 Mining has agreed to acquire mineral rights from Bold Ventures. M impact | EQUITY | Nov 02, 2026, 12:10 PM UTC SuperValu Cyber Incident Affects Refrigeration Systems at 13 Stores The Irish supermarket chain said a cyber incident affected refrigeration systems in 13 stores. M impact | EQUITY | Nov 02, 2026, 12:10 PM UTC SuperValu Cyber Incident Affects Refrigeration Systems in 13 Stores The Irish supermarket chain says a cyber incident has affected refrigeration systems in 13 stores. M impact | EQUITY | Nov 02, 2026, 12:10 PM UTC Verdera Energy to Buy Back Up to 6.39 Million Shares The company plans to repurchase up to 6.39 million shares, about 9.44% of its adjusted public float. M impact | EQUITY | Nov 02, 2026, 12:09 PM UTC Nouveau Monde Graphite Receives Mining Permit for Matawinie Mine Nouveau Monde Graphite received a mining permit for its Matawinie mine in Québec. M impact | EQUITY | Nov 02, 2026, 12:09 PM UTC